A phage-based vaccine against Tauopathies (pT181-Qβ) was developed by conjugating a peptide from Tau (175TPPAPKpTPPSSGEGGC190; named pT181) to VLPs of bacteriophage Qβ. The gene discussed is MAPT; the disease is tauopathy.